WO1994025025A3 - Systeme zur kontrollierten abgabe von pilocarpin - Google Patents
Systeme zur kontrollierten abgabe von pilocarpin Download PDFInfo
- Publication number
- WO1994025025A3 WO1994025025A3 PCT/EP1994/001281 EP9401281W WO9425025A3 WO 1994025025 A3 WO1994025025 A3 WO 1994025025A3 EP 9401281 W EP9401281 W EP 9401281W WO 9425025 A3 WO9425025 A3 WO 9425025A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pilocarpine
- controlled release
- systems
- reservoir layer
- encapsulating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94915110A EP0695182A1 (de) | 1993-04-28 | 1994-04-25 | Systeme zur kontrollierten abgabe von pilocarpin |
PL94311281A PL175077B1 (pl) | 1993-04-28 | 1994-04-25 | Przezskórny układ terapeutyczny do leczenia jaskry oraz sposób otrzymywania przezskórnego układu terapeutycznego do leczenia jaskry |
AU66481/94A AU694115B2 (en) | 1993-04-28 | 1994-04-25 | Systems for controlled release of pilocarpine |
HU9503087A HU220045B (hu) | 1993-04-28 | 1994-04-25 | Pilokarpin szabályozott leadására alkalmas transzdermális rendszer és eljárás előállítására |
SK1343-95A SK134395A3 (en) | 1993-04-28 | 1994-04-25 | Transdermal therapeutical agent and preparation method thereof |
US08/553,346 US5869086A (en) | 1993-04-28 | 1994-04-25 | Systems for the controlled release of pilocarpine |
JP6523855A JPH08509716A (ja) | 1993-04-28 | 1994-04-25 | ピロカルピンの制御放出システム |
NO954325A NO309174B1 (no) | 1993-04-28 | 1995-10-27 | Anvendelse av pilokarpin eller et av dets farmasöytisk akseptable salter for fremstilling av et transdermalt terapeutisk system |
FI955161A FI955161A (fi) | 1993-04-28 | 1995-10-27 | Systeemejä pilokarpiinin säädeltyä vapauttamista varten |
KR1019950704711A KR960702308A (ko) | 1993-04-28 | 1995-10-27 | 피로카르핀의 방출 조절 시스템 (systems for controlled release of pilocarpine) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4313928.0 | 1993-04-28 | ||
DE4313928A DE4313928C2 (de) | 1993-04-28 | 1993-04-28 | Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994025025A2 WO1994025025A2 (de) | 1994-11-10 |
WO1994025025A3 true WO1994025025A3 (de) | 1995-03-02 |
Family
ID=6486612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1994/001281 WO1994025025A2 (de) | 1993-04-28 | 1994-04-25 | Systeme zur kontrollierten abgabe von pilocarpin |
Country Status (19)
Country | Link |
---|---|
US (1) | US5869086A (de) |
EP (1) | EP0695182A1 (de) |
JP (1) | JPH08509716A (de) |
KR (1) | KR960702308A (de) |
AU (1) | AU694115B2 (de) |
CA (1) | CA2161520A1 (de) |
CZ (1) | CZ277995A3 (de) |
DE (1) | DE4313928C2 (de) |
FI (1) | FI955161A (de) |
HR (1) | HRP940270A2 (de) |
HU (1) | HU220045B (de) |
IL (1) | IL109340A (de) |
NO (1) | NO309174B1 (de) |
NZ (1) | NZ265950A (de) |
PL (1) | PL175077B1 (de) |
SK (1) | SK134395A3 (de) |
WO (1) | WO1994025025A2 (de) |
YU (1) | YU22894A (de) |
ZA (1) | ZA942874B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
AU719171B2 (en) * | 1995-01-14 | 2000-05-04 | Abbott Laboratories | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts |
WO2001026648A1 (fr) | 1999-10-13 | 2001-04-19 | Senju Pharmaceutical Co., Ltd. | Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee |
DE10246503A1 (de) * | 2002-03-26 | 2003-10-16 | Tesa Ag | Verwendung von Haftklebemassen für medizinische Verklebungen |
US20060036220A1 (en) * | 2003-01-22 | 2006-02-16 | Kohji Kawahara | Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
PL1754491T3 (pl) * | 2004-05-21 | 2010-08-31 | Senju Pharma Co | Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego |
CA2597525A1 (en) * | 2005-02-17 | 2006-08-24 | Senju Pharmaceutical Co., Ltd. | Solid ophthalmic drug for external use |
CN101232882A (zh) * | 2005-07-26 | 2008-07-30 | 千寿制药株式会社 | 经皮吸收性眼用制剂 |
US20100323978A1 (en) * | 2009-06-22 | 2010-12-23 | Calvin Hanna | Non-aqueous oil delivery system for ophthalmic drugs |
EP2606895A4 (de) * | 2010-10-12 | 2014-04-02 | Univ Wuhan | Pflaster zur transdermalen absorption eines antivirus-wirkstoffs und verfahren zu seiner herstellung |
KR101688061B1 (ko) | 2014-10-06 | 2017-01-02 | 주식회사한국파마 | 필로카르핀 경피 흡수 제제 |
JP6526475B2 (ja) * | 2015-04-30 | 2019-06-05 | サンスター株式会社 | 経皮唾液腺投与用の唾液分泌促進剤 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2163347A (en) * | 1984-08-14 | 1986-02-26 | Israel Inst Biolog Res | Drug delivery system |
EP0219207A2 (de) * | 1985-08-16 | 1987-04-22 | BAUSCH & LOMB INCORPORATED | Formulierung mit verzögerter Wirkstoffabgabe, die ein hydrophobes Polymersystem enthält |
WO1991001130A1 (en) * | 1989-07-14 | 1991-02-07 | Alza Corporation | Oral osmotic device with hydrogel driving member |
WO1993000058A1 (en) * | 1991-06-27 | 1993-01-07 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3220960A (en) * | 1960-12-21 | 1965-11-30 | Wichterle Otto | Cross-linked hydrophilic polymers and articles made therefrom |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3760805A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US3987790A (en) * | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4137300A (en) * | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
US4931279A (en) * | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
DE3743946A1 (de) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung |
US5273757A (en) * | 1987-09-01 | 1993-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Apparatus for the delivery of substances, processes for the production thereof and use thereof |
US5300291A (en) * | 1988-03-04 | 1994-04-05 | Noven Pharmaceuticals, Inc. | Method and device for the release of drugs to the skin |
US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
DE4002281A1 (de) * | 1990-01-26 | 1991-08-01 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit dem wirkstoff tulobuterol |
EP0523150A4 (en) * | 1990-04-06 | 1993-09-29 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
EP0537165B1 (de) * | 1990-04-27 | 1998-07-01 | Allergan, Inc. | Polymeres arzneimittelabgabesystem |
-
1993
- 1993-04-28 DE DE4313928A patent/DE4313928C2/de not_active Expired - Fee Related
-
1994
- 1994-04-18 IL IL10934094A patent/IL109340A/en not_active IP Right Cessation
- 1994-04-25 EP EP94915110A patent/EP0695182A1/de not_active Withdrawn
- 1994-04-25 HU HU9503087A patent/HU220045B/hu not_active IP Right Cessation
- 1994-04-25 PL PL94311281A patent/PL175077B1/pl unknown
- 1994-04-25 US US08/553,346 patent/US5869086A/en not_active Expired - Fee Related
- 1994-04-25 WO PCT/EP1994/001281 patent/WO1994025025A2/de not_active Application Discontinuation
- 1994-04-25 JP JP6523855A patent/JPH08509716A/ja active Pending
- 1994-04-25 CZ CZ952779A patent/CZ277995A3/cs unknown
- 1994-04-25 AU AU66481/94A patent/AU694115B2/en not_active Ceased
- 1994-04-25 CA CA002161520A patent/CA2161520A1/en not_active Abandoned
- 1994-04-25 SK SK1343-95A patent/SK134395A3/sk unknown
- 1994-04-25 NZ NZ265950A patent/NZ265950A/xx unknown
- 1994-04-26 ZA ZA942874A patent/ZA942874B/xx unknown
- 1994-04-27 YU YU22894A patent/YU22894A/sh unknown
- 1994-04-27 HR HRP4313928.0A patent/HRP940270A2/xx not_active Application Discontinuation
-
1995
- 1995-10-27 NO NO954325A patent/NO309174B1/no not_active IP Right Cessation
- 1995-10-27 FI FI955161A patent/FI955161A/fi unknown
- 1995-10-27 KR KR1019950704711A patent/KR960702308A/ko not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2163347A (en) * | 1984-08-14 | 1986-02-26 | Israel Inst Biolog Res | Drug delivery system |
EP0219207A2 (de) * | 1985-08-16 | 1987-04-22 | BAUSCH & LOMB INCORPORATED | Formulierung mit verzögerter Wirkstoffabgabe, die ein hydrophobes Polymersystem enthält |
WO1991001130A1 (en) * | 1989-07-14 | 1991-02-07 | Alza Corporation | Oral osmotic device with hydrogel driving member |
WO1993000058A1 (en) * | 1991-06-27 | 1993-01-07 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Also Published As
Publication number | Publication date |
---|---|
NO954325D0 (no) | 1995-10-27 |
IL109340A0 (en) | 1994-07-31 |
AU6648194A (en) | 1994-11-21 |
JPH08509716A (ja) | 1996-10-15 |
AU694115B2 (en) | 1998-07-16 |
ZA942874B (en) | 1995-07-06 |
US5869086A (en) | 1999-02-09 |
HRP940270A2 (en) | 1996-08-31 |
DE4313928C2 (de) | 1996-09-19 |
EP0695182A1 (de) | 1996-02-07 |
CA2161520A1 (en) | 1994-11-10 |
PL175077B1 (pl) | 1998-10-30 |
NO954325L (no) | 1995-10-30 |
FI955161A (fi) | 1995-11-24 |
NZ265950A (en) | 1997-08-22 |
DE4313928A1 (de) | 1994-11-03 |
IL109340A (en) | 1998-10-30 |
SK134395A3 (en) | 1997-02-05 |
KR960702308A (ko) | 1996-04-27 |
HU9503087D0 (en) | 1995-12-28 |
PL311281A1 (en) | 1996-02-05 |
FI955161A0 (fi) | 1995-10-27 |
HU220045B (hu) | 2001-10-28 |
NO309174B1 (no) | 2000-12-27 |
WO1994025025A2 (de) | 1994-11-10 |
YU22894A (sh) | 1997-08-22 |
CZ277995A3 (en) | 1996-05-15 |
HUT75029A (en) | 1997-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
US4822617A (en) | Drug delivery device | |
MY105279A (en) | Transdermal therapeutic system comprising tulobuterol as active substance. | |
CA2030178A1 (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
CA2276445A1 (en) | Transdermal hormone-delivering therapeutic system | |
WO1994025025A3 (de) | Systeme zur kontrollierten abgabe von pilocarpin | |
KR950013462B1 (en) | Plaster as a therapeutic system for the system for the step wise release of medicaments to the skin and process for its menufacture | |
WO1994008571A3 (de) | Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung | |
WO1997020582A3 (en) | Transdermal patch for comparative evaluations | |
CA2387143A1 (en) | Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin | |
CA2275769A1 (en) | Extremely flexible plaster acting dermally or transdermally, and method for producing same | |
EP0267293B1 (de) | Vorbehandlungswirkstoff zur perkutanen verabreichung | |
ID24266A (id) | Sistim terapetik transdermal yang mengandung bahan aktif basa skopolamin | |
CA2147274A1 (en) | Transdermal therapeutic system for administering physostigmin through the skin, and method of producing the system | |
US5750138A (en) | Adhesive patch for the transdermal administration of a medication | |
CA2366862A1 (en) | Transdermal therapeutic system and process for its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CZ FI HU JP KR NO NZ PL SI SK US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CZ FI HU JP KR NO NZ PL SI SK US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1995-2779 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 134395 Country of ref document: SK Ref document number: 2161520 Country of ref document: CA Ref document number: 265950 Country of ref document: NZ Ref document number: 1994915110 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 955161 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1994915110 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08553346 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: PV1995-2779 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1995-2779 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994915110 Country of ref document: EP |